1.
Male Genital Tract Chlamydial Infection : Implications for Pathology and Infertility
by CUNNINGHAM, Kelly A
Biology of reproduction, 2008, Vol.79 (2), p.180-189
2.
CBLB502, a Toll-like receptor 5 agonist, offers protection against radiation-induced male reproductive system damage in mice
by Bai, Hao
Biology of reproduction, 2018-07-30, Vol.100 (1), p.281-291
3.
Updating the Natural History of Human Papillomavirus and Anogenital Cancers
by Moscicki, Anna-Barbara
Vaccine, 2012, Vol.30 (5), p.F24-F33
4.
Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign Conditions
by Giuliano, Anna R
Vaccine, 2008, Vol.26 (10), p.K17-K28
5.
Absence of CFAP69 Causes Male Infertility due to Multiple Morphological Abnormalities of the Flagella in Human and Mouse
by Dong, Frederick N
American journal of human genetics, 2018-04-05, Vol.102 (4), p.636-648
6.
Biallelic Mutations in CFAP43 and CFAP44 Cause Male Infertility with Multiple Morphological Abnormalities of the Sperm Flagella
by Tang, Shuyan
American journal of human genetics, 2017-06-01, Vol.100 (6), p.854-864
7.
Nutritional modifications in male infertility: a systematic review covering 2 decades
by Giahi, Ladan
Nutrition reviews, 2016-02, Vol.74 (2), p.118-130
8.
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Glob...
by Abd-Allah, Foad
The Lancet (British edition), 2017-09-16, Vol.390 (10100), p.1211-1259
9.
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialis...
by Biganzoli, Laura, Dr
The lancet oncology, 2012, Vol.13 (4), p.e148-e160
10.
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results fr...
by Krop, Ian E, Dr
The lancet oncology, 2017, Vol.18 (6), p.743-754
11.
Fertility preservation in men with cancer
by Tournaye, Herman, Prof
The Lancet (British edition), 2014, Vol.384 (9950), p.1295-1301
12.
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall...
by Diéras, Véronique, Dr
The lancet oncology, 2017, Vol.18 (6), p.732-742
13.
Understanding disparities in HIV infection between black and white MSM in the United States
by OSTER, Alexandra M
AIDS (London), 2011, Vol.25 (8), p.1103-1112
14.
The 21-Gene Recurrence Score in Male Breast Cancer
by Turashvili, Gulisa
Annals of surgical oncology, 2018-03-08, Vol.25 (6), p.1530-1535
15.
Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
by Nguyen, Toan T
Annals of surgical oncology, 2018-07-05, Vol.25 (9), p.2596-2602
16.
Male Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union
by Hauser, Russ
The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.1267-1277
17.
Polygyny and extra-pair paternity enhance the opportunity for sexual selection in blue tits
by Vedder, Oscar
Behavioral ecology and sociobiology, 2011-04-01, Vol.65 (4), p.741-752
18.
Demand for male contraception
by Dorman, Emily
Expert review of pharmacoeconomics & outcomes research, 2012-10-01, Vol.12 (5), p.605-613
19.
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
by Aluwini, Shafak, Dr
The lancet oncology, 2015, Vol.16 (3), p.274-283
20.
Biallelic SUN5 Mutations Cause Autosomal-Recessive Acephalic Spermatozoa Syndrome
by Zhu, Fuxi
American journal of human genetics, 2016-10-06, Vol.99 (4), p.942-949
